Supports basic science research into the mechanisms, etiology, and pathogenesis of cystic fibrosis to inform prevention and therapy development.
2026–2027 In-Cycle Grants Award Program supports researchers studying alpha-1 antitrypsin biology and deficiency to improve health, advance treatment and care, and work toward a cure.
Alnylam Pharmaceuticals’ Educational Grants fund independent educational projects advancing clinical knowledge in ATTR amyloidosis, AHP, and PH1.
Postdoctoral Research Fellowship supports early-career researchers in mentored studies of alpha-1 antitrypsin deficiency to advance treatment and care while building research careers.
AAMDSIF Research Grants Program supports new investigators studying aplastic anemia, MDS, and PNH through research aimed at improving understanding, treatment, and outcomes in bone marrow failure disorders.